Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

OneMedNet (ONMD) Cash & Equivalents (2022 - 2025)

OneMedNet (ONMD) has disclosed Cash & Equivalents for 4 consecutive years, with $1.6 million as the latest value for Q2 2025.

  • On a quarterly basis, Cash & Equivalents rose 292.63% to $1.6 million in Q2 2025 year-over-year; TTM through Jun 2025 was $1.6 million, a 292.63% increase, with the full-year FY2024 number at $2.8 million, up 5961.7% from a year prior.
  • Cash & Equivalents was $1.6 million for Q2 2025 at OneMedNet, up from $144000.0 in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $2.8 million in Q4 2024 to a low of $1537.0 in Q3 2023.
  • A 4-year average of $791319.0 and a median of $268326.5 in 2022 define the central range for Cash & Equivalents.
  • Peak YoY movement for Cash & Equivalents: tumbled 99.35% in 2023, then surged 140173.26% in 2024.
  • OneMedNet's Cash & Equivalents stood at $301730.0 in 2022, then plummeted by 84.42% to $47000.0 in 2023, then skyrocketed by 5961.7% to $2.8 million in 2024, then plummeted by 43.91% to $1.6 million in 2025.
  • Per Business Quant, the three most recent readings for ONMD's Cash & Equivalents are $1.6 million (Q2 2025), $144000.0 (Q1 2025), and $2.8 million (Q4 2024).